NCT06145438View on ClinicalTrials.gov

Comparing the Safety and Efficacy in the Use of Hormonal Therapy on Endometriosis Patients After Conservative Surgery

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 4, 2023

Primary Completion Date

August 19, 2024

Study Completion Date

November 19, 2024

Conditions

Endometriosis Ovary

Interventions

DRUG

Dienogest

Drug is administered orally at the same time every day

DRUG

Depo Medroxyprogesterone acetate

Drug is injected intramuscularly on the buttock

DRUG

Leuprolide (as Leuprolide Acetate)

Drug is injected intramuscularly on the buttock

DRUG

Levonogestrel + etinilestradiol (30 mcg, brand name Mycrogynon)

Drug is administered orally at the same time every day

Trial Locations (1)

50244

Kariadi Hospital, Semarang

All Listed Sponsors

lead

Universitas Diponegoro

OTHER

NCT06145438 - Comparing the Safety and Efficacy in the Use of Hormonal Therapy on Endometriosis Patients After Conservative Surgery | Biotech Hunter | Biotech Hunter